Taofeek Owonikoko
Taofeek Kunle Owonikoko
| |
|---|---|
| A mụrụ ya | |
| Alma mater |
|
| Ọrụ sayensị | |
| Ụlọ ọrụ | Mahadum Emory Mahadum Johns Hopkins |
| Akwụkwọ edemede | Genetische Heterogenität na Adenokarzinomen des Ösophagus (2000) |
Taofeek Kunle Owonikoko bụ dọkịta Amerịka, Prọfesọ na Osote Onyeisi maka Mmepe Ndị nkuzi, Ngalaba Hematology na Medical Oncology na Winship Cancer Institute. Nnyocha ya na-atụle kansa akpa ume obere mkpụrụ ndụ. Ọ bụ onye otu 2019 Emory University Woodruff Leadership Academy Fellow . [1]
Mbido ndụ na agụmakwụkwọ
[dezie | dezie ebe o si]Owonikoko si Naịjirịa. Ọ gara Mahadum Obafemi Awolowo, ebe ọ bụ ọkachamara na ọgwụ. [citation needed] Owonikoko gụsịrị akwụkwọ na Lagos University Teaching Hospital. N'afọ 1998, e nyere ya nkwado nyocha nke Germany iji sonye na Mahadum Heinrich Heine Düsseldorf. [citation needed] Mgbe ọ nọ na Germany, Owonikoko nwetara nzere doctoral na anatomical pathology.
Nnyocha na ọrụ
[dezie | dezie ebe o si]N'afọ 2001, Owonikoko sonyeere Mahadum Johns Hopkins dị ka onye na-arụ ọrụ postdoctoral, ebe ọ rụrụ ọrụ na molecular imaging.[2] A họpụtara Owonikoko dị ka Ọkà Mmụta Ọrịa Kansa Pụrụ Iche na Georgia Cancer Coalition n'afọ 2008. N'afọ ahụ, ọ sonyeere Mahadum Emory dị ka prọfesọ osote ya.[3]
Ọ bụ ọkachamara na obere mkpụrụ ndụ kansa akpa ume. [citation needed] Ọ na-eduga nnwale ahụike n'ime ọgwụ ọhụrụ immunotherapy, nke a pụrụ iji gwọọ ọrịa kansa na-eme ihe ike na nke na-eme ugboro ugboro.[4] Ọ mụọla ịdị irè nke talazoparib dị ka ọgwụgwọ maka ndị ọrịa kansa akpa ume nke obere mkpụrụ ndụ nwere ụkọ mmezi homologous recombination.[5]
Owonikoko akpọọla ka ọtụtụ ndị na-acha ọbara ọbara tinye aka na nnwale ọrịa kansa.[6] Karịsịa, ndị ọrịa ojii dị n'okpuru 4% nke ndị ọrịa sonyere na nnwale ahụike maka kansa akpa ume.[6] O kwenyere na nnọchiteanya a na-eme ka enweghị nhata nke nlekọta ahụike.[6]
Onyinye na nsọpụrụ
[dezie | dezie ebe o si]- 2008 Ònye bụ Ònye[7]
- 2016 National Cancer Institute Cancer Clinical Investigator Team Leadership Award [8]
- 2019 Emory University Woodruff Leadership Academy Fellow [9]
Akwụkwọ ndị a họọrọ
[dezie | dezie ebe o si]- Owonikoko (2007-12-10). "Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results Database" (in en). Journal of Clinical Oncology 25 (35): 5570–5577. DOI:10.1200/JCO.2007.12.5435. ISSN 0732-183X. PMID 18065729.
- Ramalingam (2011-03-08). "Lung cancer: New biological insights and recent therapeutic advances" (in en). CA: A Cancer Journal for Clinicians 61 (2): 91–112. DOI:10.3322/caac.20102. PMID 21303969.
- Owonikoko (2016). "First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70" (in en). Cancer Chemotherapy and Pharmacology 77 (1): 155–162. DOI:10.1007/s00280-015-2909-2. ISSN 0344-5704. PMID 26576779.
Edemsibịa
[dezie | dezie ebe o si]- ↑ Templeeti:Cite thesis
- ↑ Templeeti:Cite thesis
- ↑ Templeeti:Cite thesis
- ↑ Templeeti:Cite thesis
- ↑ Templeeti:Cite thesis
- ↑ 6.0 6.1 6.2 Nazha (2019-05-01). "Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy". American Society of Clinical Oncology Educational Book 39 (39): 3–10. DOI:10.1200/EDBK_100021. ISSN 1548-8748. PMID 31099618.
- ↑ Templeeti:Cite thesis
- ↑ Templeeti:Cite thesis
- ↑ Templeeti:Cite thesis